1. Home
  2. GEF vs IOVA Comparison

GEF vs IOVA Comparison

Compare GEF & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greif Inc.

GEF

Greif Inc.

HOLD

Current Price

$70.13

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.85

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEF
IOVA
Founded
1877
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GEF
IOVA
Price
$70.13
$2.85
Analyst Decision
Hold
Buy
Analyst Count
4
12
Target Price
$69.50
$10.45
AVG Volume (30 Days)
279.3K
11.3M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
3.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,290,654,188.00
$250,425,000.00
Revenue This Year
$2.73
$60.71
Revenue Next Year
$1.70
$59.52
P/E Ratio
$3.62
N/A
Revenue Growth
N/A
175.62
52 Week Low
$48.23
$1.64
52 Week High
$70.89
$8.15

Technical Indicators

Market Signals
Indicator
GEF
IOVA
Relative Strength Index (RSI) 68.57 69.24
Support Level $67.15 $2.08
Resistance Level $70.89 $2.60
Average True Range (ATR) 1.48 0.17
MACD -0.05 0.07
Stochastic Oscillator 87.48 87.36

Price Performance

Historical Comparison
GEF
IOVA

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: